Shire Human Genetic Therapies and a string of smaller drug developers have decided to pull up stakes from Cambridge and head for the suburbs. The report says the exodus is being triggered by a desire to find less expensive digs. The city has contributed to creating one of the biggest biotech clusters in the world [1], but developers have been balking at the high rents they face in town. For growing companies, the desire to get everyone under one roof can be a particular challenge.
- read the article [2] in the Boston Globe
Related Articles:
Shire to Massachusetts: Pass incentive bill now. Report [3]
Boston biotech booming as scientific research flourishes. Report [4]
Mass. House backs $1B life sciences initiative. Report [1]
Links:
[1] http://www.fiercebiotech.com/story/mass.-house-backs-1b-life-sciences-initiative/2008-02-28
[2] http://www.boston.com/business/healthcare/articles/2008/03/01/cambridge_biotech_firms_departing_city_for_suburbs/
[3] http://www.fiercebiotech.com/story/shire-massachusetts-pass-incentive-bill-now/2007-08-31
[4] http://www.fiercebioresearcher.com/story/boston-biotech-booming-as-scientific-research-flourishes/2007-05-15